Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Publication year range
1.
J Intern Med ; 252(3): 271-5, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12270009

ABSTRACT

A 75-year-old woman with Glanzmann's thrombasthenia was admitted because of persistent melaena. Endoscopic examination showed multiple angiodysplastic lesions, with active bleeding in small and large bowel. Electro-coagulation of some lesions, octreotide, conjugated oestrogens and selective embolization of jejunal vessels did not change transfusion requirements. After 8 month-transfusions, ethinylestradiol + norethisterone in association with octreotide was started, leading to no transfusion over the following 9 months. Bleeding recurred after withdrawing octreotide and substituting ethinylestradiol + norgestrel for the ethinylestradiol + norethisterone combination. Re-introduction of octreotide did not improve bleeding; however, a reduction of transfusion requirement was observed when the ethinylestradiol + norethisterone pill was re-administered. The association of octreotide and of an oestrogen-progesterone combination was helpful in the difficult management of recurrent bleeding in this patient with diffuse gastrointestinal vascular abnormalities and a severe condition predisposing to bleeding.


Subject(s)
Angiodysplasia/complications , Intestinal Diseases/complications , Melena/etiology , Thrombasthenia/complications , Thrombasthenia/drug therapy , Aged , Anemia/etiology , Anemia/therapy , Angiodysplasia/diagnosis , Angiodysplasia/therapy , Blood Transfusion , Drug Therapy, Combination , Electrocoagulation , Estradiol Congeners/administration & dosage , Ethinyl Estradiol/administration & dosage , Female , Gastrointestinal Agents/administration & dosage , Hemostatics/administration & dosage , Humans , Intestinal Diseases/therapy , Melena/diagnosis , Melena/therapy , Norethindrone/administration & dosage , Octreotide/administration & dosage , Progesterone Congeners/administration & dosage , Recurrence , Treatment Outcome
2.
Thromb Haemost ; 81(4): 486-92, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10235425

ABSTRACT

Giant platelets in the blood smear, absent in vitro platelet agglutination in response to ristocetin, and normal aggregation, ATP secretion and thromboxane B2 formation were found in a young patient with a life-long bleeding tendency. Ristocetin-induced von Willebrand factor binding to her platelets was less than 10% of normal. Flow cytometric analysis with monoclonal antibodies LJ-Ib-1, LJ-Ib-10, and LJ-P3 was consistent with the latter finding. SDS-PAGE analysis of solubilized platelets showed a marked reduction of the platelet glycoprotein (GP) Ibalpha. Genetic characterisation demonstrated that the patient and her father were heterozygous for a deletion of 36 nucleotides (positions 554-589) leading to a mutant GPIalpha (deletion of aminoacids from residue 169 to 180 and a Glu --> Lys substitution at residue 181). In addition, a C --> T transition at nucleotide 515 in the other allele of the GPIbalpha gene was found in the patient and in her mother that results in the substitution of alanine for valine in codon 156 (Bernard-Soulier type Bolzano). These variations occurred within the VI and VII leucine-rich repeats. The novel variant of Bernard-Soulier syndrome identified further suggests that the integrity of leucine-rich repeats is important for normal function of the GP Ib-IX-V receptor complex.


Subject(s)
Bernard-Soulier Syndrome/genetics , Genetic Heterogeneity , Platelet Glycoprotein GPIb-IX Complex/genetics , Adult , Bernard-Soulier Syndrome/diagnosis , Blood Platelets/chemistry , Family Health , Female , Humans , Polymorphism, Single-Stranded Conformational , Sequence Analysis, DNA
3.
Electrophoresis ; 19(8-9): 1468-74, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9694297

ABSTRACT

Glanzmann thrombasthenia (GT) is an inherited hemorrhagic defect due to a failure of the platelet membrane glycoprotein (GP) IIb-IIIa complex. Capillary electrophoresis (CE) analysis of solubilized platelet membranes from normal individuals showed the presence of two peaks with a migration time of 27 and 29 min, respectively. An excellent run-to-run and day-to-day reproducibility of the technique (< 1% variation of the retention time) was documented. Using an automated Ferguson method, the apparent molecular masses were 100.0 kDa and 138.5 kDa, respectively. Immunoprecipitation with monoclonal antibodies anti-GP IIIa (B59.2.1) and anti-IIb (61.9.1.3) showed the two peaks as IIIa and IIb, respectively. Electropherograms of a GT young man showed the lack of both peaks. Less than 50% of each peak was present in his parents. Polyacrylamide gel electrophoresis (PAGE), immunoblotting, and flow cytometry analyses showed that GP IIb and IIIa were undetectable in the platelet membranes from the propositus, half of the normal amount being present in both parents. These findings indicate CE to be a rapid, sensitive and reliable tool to investigate patients with abnormalities of the GP IIb-IIIa complex.


Subject(s)
Electrophoresis, Capillary/methods , Platelet Glycoprotein GPIIb-IIIa Complex/analysis , Blood Platelets/metabolism , Cell Membrane/metabolism , Child , Flow Cytometry , Humans , Male , Membrane Glycoproteins/analysis , Precipitin Tests , Thrombasthenia/blood
6.
Cancer ; 61(1): 76-83, 1988 Jan 01.
Article in English | MEDLINE | ID: mdl-2446734

ABSTRACT

Cancer antigen 125 (CA 125) is common to most epithelial ovarian tumors. Therefore, it is potentially a good marker of this disease. This hypothesis was evaluated by measuring the serum levels of CA 125 in 81 patients with ovarian cancer (25 with nonactive and 56 with active disease), in 105 patients of both sexes with nonovarian tumors, and in 171 healthy controls of both sexes. The serum levels of three other markers, tissue polypeptide antigen (TPA), carcinoembryonic antigen (CEA), and human chorionic gonadotropin, beta subunit (beta-hCG), were also measured in the same 357 subjects. The results of this study clearly indicate the clinical irrelevance of both CEA and beta-hCG as tumor markers in ovarian carcinomas. Conversely, the clinical usefulness of CA 125 and TPA was confirmed. In particular, CA 125 and TPA showed comparable sensitivity, while CA 125 showed a higher specificity for ovarian cancer than TPA. The association of CA 125 with TPA was very useful in continuous observation of patients with active disease in order to evaluate the clinical effectiveness of the therapy. Moreover, for patients in clinical remission, the markers allowed early detection of a recurrence of the disease.


Subject(s)
Antigens, Neoplasm/analysis , Biomarkers, Tumor/blood , Carcinoembryonic Antigen/analysis , Carcinoma/blood , Chorionic Gonadotropin/analysis , Ovarian Neoplasms/blood , Peptide Fragments/analysis , Peptides/analysis , Adult , Aged , Antigens, Tumor-Associated, Carbohydrate , Chorionic Gonadotropin, beta Subunit, Human , Female , Humans , Middle Aged , Tissue Polypeptide Antigen
7.
Boll Soc Ital Biol Sper ; 60(2): 325-9, 1984 Feb 28.
Article in Italian | MEDLINE | ID: mdl-6712790

ABSTRACT

The authors present their findings on the HLA A and B antigens frequent in Campania by means of a 127 random people sample. Only the HLA 1-8 aplotype shows a clear crossing-over disequilibrium.


Subject(s)
Alleles , Gene Frequency , HLA Antigens/genetics , Humans , Mathematics
8.
J Med Genet ; 20(6): 419-21, 1983 Dec.
Article in English | MEDLINE | ID: mdl-6655667

ABSTRACT

A large kindred (64 members in four generations), affected by a form of apparently congenital pulverulent cataract, was studied for linkage of its gene locus with that of the Fy blood group. No indication of linkage was found. The involvement of the cortex distinguishes this form from the zonular pulverulent cataract (total nuclear) of Nettleship and Ogilvie, the locus of which is probably linked with Fy. A correlation between morphological and genetic heterogeneity, based on the linkage with Fy, cannot be established because of the scarcity of published data.


Subject(s)
Blood Group Antigens/genetics , Cataract/genetics , Duffy Blood-Group System/genetics , Cataract/blood , Cataract/congenital , Female , Humans , Lod Score , Male , Phenotype
SELECTION OF CITATIONS
SEARCH DETAIL
...